SCHEMBL6155871

SCHEMBL6155871

Cc1ccc(NNNC=S)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.53
RAPGEF4 Q8WZA2 1/20 0.45
GAA P10253 6/20 0.43
ALDH1A1 P00352 4/20 0.40
AGTR1 P30556 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
LMNA P02545 1/20 0.40
GFER P55789 1/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HTT P42858 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HPGD P15428 1/20 0.39
PPIA P62937 1/20 0.38
TSHR P16473 1/20 0.38
EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5271023 0.84 MAPT (0.49) MAPTRAPGEF4GAAALDH1A1MEN1
SCHEMBL6665990 0.78 MAPT (0.54) MAPTRAPGEF4GAAALDH1A1AGTR1
SCHEMBL6666096 0.78 MAPT (0.50) MAPTRAPGEF4GAAALDH1A1MEN1
SCHEMBL10987757 0.74 MAPT (0.58) MAPTRAPGEF4GAAALDH1A1AGTR1
SCHEMBL10516773 0.69 MAPT (0.71) MAPTRAPGEF4GAAALDH1A1AGTR1
SCHEMBL3624226 0.69 RAPGEF4 (0.57) MAPTRAPGEF4GAAALDH1A1AGTR1
SCHEMBL9513146 0.69 RAPGEF4 (0.68) MAPTRAPGEF4GAAALDH1A1MEN1
SCHEMBL15540565 0.68 MAPT (0.65) MAPTGAAALDH1A1AGTR1LMNA
SCHEMBL1143502 0.67 RAPGEF4 (0.55) MAPTRAPGEF4GAAALDH1A1AGTR1
Hydrochloric Acid SCHEMBL27585338 0.67 RAPGEF4 (0.55) MAPTRAPGEF4GAAALDH1A1AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP MAPT 3318/4885RAPGEF4 3378/4885GAA 2365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.